Centre Hospitalier Universitaire de Tivoli
La Louvière 7100
1 studies enrolling now · 1 studies all time
What they study most
End Stage Kidney Disease
Studies at this site
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
— Recruiting now